Urinary incontinence in women. Stress incontinence (female) (Urinary)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Married women aged 20 to 51 years No permanent (divorce) or temporary separation from spouse At least 8 weeks since last delivery (if applicable) Sexually active No use of medications affecting sexual function in participants or spouses, including sedatives, addictive drugs (opioids, hallucinogens), cardiac and antihypertensive drugs, and anticonvulsants No addiction to drugs or alcohol in couples No abnormal uterine bleeding No severe uterine prolapse No history of surgery on back, pelvis, or abdomen within the last month No history of diseases affecting sexual function in participants or their spouses, including:Central nervous system diseases (multiple sclerosis, myasthenia gravis)Severe depression and bipolar disorderLimb paralysisVaginismusHeart diseaseDrug-dependent diabetesTumors, masses, and cancerThyroid disordersVasculitisAdrenal cortex diseases (Cushing's syndrome, adrenal insufficiency)HypertensionPulmonary and liver diseasesPeripheral neuropathies Obstetric history: previous vaginal delivery
Exclusion criteria
Exclusion criteria: Participant’s dissatisfaction or non-cooperation at any stage Presence of vaginal inflammation or infection during the study Presence of wounds, bleeding, or infection in vagina or urinary tract during the study Use of any medication or treatment for urinary incontinence during the study Emotional stress such as death of a first-degree relative within the past three months Presence of menopausal symptoms Regular gym exercise for more than one month
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Determination and comparison of the mean female sexual function score in women with urinary incontinence in three groups: exercise therapy, pelvic floor biofeedback, and exercise therapy combined with biofeedback before and immediately after intervention. Timepoint: Before intervention and immediately after intervention. Method of measurement: The primary outcome will be measured using the Female Sexual Function Index (FSFI), a validated 19-item questionnaire evaluating six domains of sexual function over the past four weeks. Additional demographic data including age, residence, education level, occupation, number of pregnancies, ethnicity, duration of urinary incontinence, and type of delivery will be collected via a demographic questionnaire.;Determination and comparison of the mean female sexual satisfaction score in women with urinary incontinence in three groups: exercise therapy, pelvic floor biofeedback, and exercise therapy combined with biofeedback before and immediately after intervention. Timepoint: Before intervention and immediately after intervention. Method of measurement: The second outcome will be measured using the Larson Sexual Satisfaction Questionnaire (LSSQ) (1988). This questionnaire consists of 25 items covering four components: sexual desire, sexual attitude, quality of sexual life, and sexual compatibility. Responses are scored on a five-point Likert scale ranging from 1 to 5, where 1 = never, 2 = rarely, 3 = sometimes, 4 = often, and 5 = always. Thirteen items (numbers 4, 5, 6, 7, 8, 9, 11, 14, 15, 18, 20, 24, and 25) are reverse scored. Total scores range from 25 to 125, representing the level of sexual satisfaction.;Determination and comparison of the type and severity of urinary incontinence in women with urinary incontinence in three groups: exercise therapy, pelvic floor biofeedback, and exercise therapy combined with biofeedback before and immediately after intervention. Timepoint: Before intervention and immediately after interventi | — |
Countries
Iran (Islamic Republic of)
Contacts
Shahre-kord University of Medical Sciences